Agonist anti-ChemR23 mAb reduces tissue neutrophil accumulation and triggers chronic inflammation resolution-Reference-Cited by-同舟云学术

Agonist anti-ChemR23 mAb reduces tissue neutrophil accumulation and triggers chronic inflammation resolution

Published:2021-04-02 Issue:14 Volume:7 Page:
ISSN:2375-2548
Container-title:Science Advances
language:en
Short-container-title:Sci. Adv.

Author:

Trilleaud C.¹²^ORCID,Gauttier V.¹^ORCID,Biteau K.¹,Girault I.¹,Belarif L.¹,Mary C.¹,Pengam S.¹,Teppaz G.¹,Thepenier V.¹,Danger R.²³⁴^ORCID,Robert-Siegwald G.⁵^ORCID,Néel M.²³⁴,Bruneau S.²⁴^ORCID,Glémain A.²⁴,Néel A.²³⁶,Poupon A.⁷^ORCID,Mosnier J. F.²³⁸,Chêne G.⁹,Dubourdeau M.⁹^ORCID,Blancho G.²³⁴^ORCID,Vanhove B.¹^ORCID,Poirier N.¹^ORCID

Affiliation:

1. OSE Immunotherapeutics, Nantes, France.

2. Université de Nantes,

3. [CHU Nantes], INSERM, Centre de Recherche en Transplantation et Immunologie, UMR 1064,

4. [ITUN], 44000 Nantes, France.

5. Inovarion, Paris, France.

6. Service de Médecine Interne, CHU de Nantes, Nantes, France.

7. MabSillico, Nouzilly, France.

8. Service d’Anatomie et Cytologie Pathologiques, CHU Nantes, Nantes, France.

9. Ambiotis, Canal Biotech 2, Toulouse, France.

Abstract

Agonistic proresolutive monoclonal antibody reverses chronic inflammation.